Manufacturing / Lab Analytical Instruments
STANDARD BIOTOOLS INC.
LAB
$0.70
+$0.06 (+8.60%)
Price as of Nov 13, 2026 22:20 UTC
290 M
Market Cap (Micro Cap)
Feb 10
Next Earnings
Technical Signals
as of Nov 13
Mixed
3 of 7
Trend
- Above 20-day average $0.65
- Above 50-day average $0.68
- Above 200-day average $0.90 · -21.3%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 108d ago
Volume
- Elevated volume 1.8x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for LAB options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
16 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Nov 05, 2026 | Carey Thomas D. | Buy | 75,000 | $46,898 | +13.5% | |
| Aug 20, 2026 | Egholm Michael | Tax_withholding | 97,627 | $65,605 | +5.7% | |
| Aug 20, 2026 | Kim Hanjoon Alex | Tax_withholding | 28,195 | $18,947 | +5.7% | |
| Aug 20, 2026 | Mackay Sean | Tax_withholding | 25,729 | $17,290 | +5.7% | |
| Aug 03, 2026 | Egholm Michael | Tax_withholding | 362,625 | $314,759 | -18.2% | |
| Jul 23, 2026 | Kim Hanjoon Alex | Tax_withholding | 202,476 | $181,216 | -20.7% | |
| Jun 20, 2026 | Mackay Sean | Grant | 500,000 | $0 | -7.8% | |
| Jun 18, 2026 | Witney Frank | Grant | 99,116 | $0 | -14.5% | |
| Jun 18, 2026 | Carey Thomas D. | Grant | 263,884 | $0 | -14.5% | |
| Jun 18, 2026 | HIBBS KATHY L | Grant | 175,923 | $0 | -14.5% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Nov 10, 2026 | Q3 2026 | -$0.02 | |||
| Nov 02, 2026 | Q3 2026 | -$0.02 | |||
| Jun 30, 2026 | Q2 2026 | -$0.01 | -$0.03 | -129.0% | Miss |
| Mar 31, 2026 | Q1 2026 | -$0.05 | $0.33 | +800.6% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.07 | $0.05 | +170.7% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.06 | -$0.09 | -61.9% | Miss |
Track LAB with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for LAB and your entire portfolio.